PeterLabs Holdings Berhad Balance Sheet Health

Financial Health criteria checks 5/6

PeterLabs Holdings Berhad has a total shareholder equity of MYR80.4M and total debt of MYR18.6M, which brings its debt-to-equity ratio to 23.1%. Its total assets and total liabilities are MYR114.8M and MYR34.4M respectively. PeterLabs Holdings Berhad's EBIT is MYR6.2M making its interest coverage ratio 8.1. It has cash and short-term investments of MYR16.1M.

Key information

23.1%

Debt to equity ratio

RM18.57m

Debt

Interest coverage ratio	8.1x
Cash	RM16.10m
Equity	RM80.40m
Total liabilities	RM34.35m
Total assets	RM114.76m

Recent financial health updates

PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly

Nov 10

Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?

Jan 28

Recent updates

PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly

Nov 10

Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?

Jan 28

With EPS Growth And More, PeterLabs Holdings Berhad (KLSE:PLABS) Makes An Interesting Case

Nov 10

Is Now The Time To Put PeterLabs Holdings Berhad (KLSE:PLABS) On Your Watchlist?

Feb 02

Are PeterLabs Holdings Berhad's (KLSE:PLABS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Dec 28

Are PeterLabs Holdings Berhad's (KLSE:PLABS) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 30

Financial Position Analysis

Short Term Liabilities: PLABS's short term assets (MYR80.0M) exceed its short term liabilities (MYR31.0M).

Long Term Liabilities: PLABS's short term assets (MYR80.0M) exceed its long term liabilities (MYR3.4M).

Debt to Equity History and Analysis

Debt Level: PLABS's net debt to equity ratio (3.1%) is considered satisfactory.

Reducing Debt: PLABS's debt to equity ratio has increased from 17.4% to 23.1% over the past 5 years.

Debt Coverage: PLABS's debt is well covered by operating cash flow (28.8%).

Interest Coverage: PLABS's interest payments on its debt are well covered by EBIT (8.1x coverage).

PeterLabs Holdings Berhad Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly

Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?

Recent updates

New major risk - Revenue and earnings growth

Full year 2023 earnings released: EPS: RM0.013 (vs RM0.013 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.005 (vs RM0.003 in 3Q 2022)

New minor risk - Share price stability

PeterLabs Holdings Berhad (KLSE:PLABS) Seems To Use Debt Quite Sensibly

New major risk - Market cap size

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.003 in 2Q 2022)

Peterlabs Holdings Berhad Announces Appointment of Dato Lim Tai Soon Independent and Non Executive Chairman

First quarter 2023 earnings released: EPS: RM0.003 (vs RM0.004 in 1Q 2022)

PeterLabs Holdings Berhad Announces Retirement of Dato Hon Choon Kim Independent and Non Executive Chairman

Full year 2022 earnings released: EPS: RM0.013 (vs RM0.021 in FY 2021)

Is PeterLabs Holdings Berhad (KLSE:PLABS) A Risky Investment?

Third quarter 2022 earnings released: EPS: RM0.003 (vs RM0.006 in 3Q 2021)

PeterLabs Holdings Berhad Appoints Loh Poh Im as Independent and Non-Executive Chairman of Risk Committee

High number of new directors

With EPS Growth And More, PeterLabs Holdings Berhad (KLSE:PLABS) Makes An Interesting Case

Second quarter 2022 earnings released: EPS: RM0.003 (vs RM0.003 in 2Q 2021)

Peterlabs Holdings Berhad Announces the Resignation of Young Wou Jian as Company Secretary

High number of new directors

PeterLabs Holdings Berhad Announces Resignation of Yap Siaw Peng as Executive Member of Remuneration Committee

Peterlabs Holdings Berhad Announces Appointment of Loh Poh Im as Independent and Non Executive Director

PeterLabs Holdings Berhad Announces Retirement of Vijaya Raghavan A/L M P Nair as Independent and Non Executive Member of Nomination Committee

Peterlabs Holdings Berhad Announces Single Tier Interim Dividend for the Fiscal Year Ending 31 December, 2022, Payable on July 22, 2022

Peterlabs Holdings Berhad Announces Resignation of Wong Yuet Chyn as Company Secretary

First quarter 2022 earnings released: EPS: RM0.004 (vs RM0.005 in 1Q 2021)

PeterLabs Holdings Berhad, Annual General Meeting, Jun 29, 2022

Peterlabs Holdings Berhad Announces Appointment of YOUNG WOU JIAN as Company Secretary

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2021 earnings released: EPS RM0.003 (vs RM0.004 in 2Q 2020)

First quarter 2021 earnings released: EPS RM0.005 (vs RM0.004 in 1Q 2020)

Full year 2020 earnings released: EPS RM0.017 (vs RM0.02 in FY 2019)

Full year 2020 earnings released: EPS RM0.016 (vs RM0.02 in FY 2019)

Is Now The Time To Put PeterLabs Holdings Berhad (KLSE:PLABS) On Your Watchlist?

PeterLabs Holdings Berhad (KLSE:PLABS) completed the acquisition of 60% stake in THYE ON TONG TRADING SDN BHD from Datuk Loh Saw Foong and Datin Lin Ching Yein.

Are PeterLabs Holdings Berhad's (KLSE:PLABS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Peterlabs Holdings Berhad Announces the Appointment of Dato' Ng Boon Siong as Independent and Non Executive Director

Third quarter 2020 earnings released: EPS RM0.006

Are PeterLabs Holdings Berhad's (KLSE:PLABS) Statutory Earnings A Good Reflection Of Its Earnings Potential?

New 90-day low: RM0.21

New 90-day low: RM0.21

PeterLabs Holdings Berhad Announces Retirement of Encik Azman Bin Abdul Jalil as Independent and Non Executive Director

PeterLabs Holdings Berhad (KLSE:PLABS) signed a conditional share sale agreement to acquire 60% stake in THYE ON TONG TRADING SDN BHD from Datuk Loh Saw Foong and Datin Lin Ching Yein for MYR 14.5 million.

PeterLabs Holdings Berhad has completed a Follow-on Equity Offering in the amount of MYR 4.423642 million.

First half earnings released

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies